Papers
1
Total Citations
21
H-Index
1
About
Dr. Jinye Xu is a leading thoracic surgeon whose research focuses on advancing minimally invasive techniques for esophageal cancer treatment, particularly through robotic-assisted surgery. His major contribution lies in rigorously comparing surgical outcomes between robot-assisted and conventional minimally invasive McKeown esophagectomy. In his landmark 2022 systematic review and meta-analysis—cited 21 times—Dr. Xu synthesized data from over 1,000 patients, demonstrating that robotic approaches can reduce operative blood loss and shorten hospital stays while maintaining oncologic safety. This work provides critical evidence for surgeons adopting robotic platforms, directly influencing clinical guidelines and patient care pathways. Beyond this meta-analysis, Dr. Xu’s broader research portfolio explores perioperative optimization and long-term quality of life after esophagectomy, bridging technical innovation with patient-centered outcomes. His findings have been presented at international thoracic surgery conferences, earning recognition for advancing precision in esophageal oncology. For students and researchers, Dr. Xu exemplifies how systematic evidence synthesis can translate surgical technology into measurable clinical benefit, making him a pivotal figure in the evolution of robotic thoracic surgery.
Research Focus
Key Achievements
Top Papers
- 1